Volume 123, Issue 1, Pages (July 2002)

Slides:

Advertisements

Similar presentations

Celiac disease–like abnormalities in a subgroup of patients with irritable bowel syndrome Ulrich Wahnschaffe, R. Ullrich, E.O. Riecken, J.D. Schulzke Gastroenterology.

Advertisements

Risk Factors for Hepatocellular Carcinoma in Patients With Alcoholic or Viral C Cirrhosis Gisèle N’Kontchou, Jacques Paries, Myint Tin Tin Htar, Nathalie.

It's time to bring the best and brightest back to gastroenterology!

Volume 39, Issue 6, Pages (December 2003)

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection Yi–Cheng Chen, I.–Shyan Sheen,

Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

From Fat to Inflammation

Volume 117, Issue 1, Pages (July 1999)

Changing pattern of chronic hepatitis D in Southern Europe

Diagnosis of irritable bowel syndrome

Volume 119, Issue 2, Pages (August 2000)

Leptin, obesity, and liver disease

Nonalcoholic steatohepatitis

Systematic review of the comorbidity of irritable bowel syndrome with other disorders: What are the causes and implications? William E. Whitehead, Olafur.

Risk of de novo Hepatocellular Carcinoma after HCV Treatment with Direct-Acting Antivirals Liver Cancer - DOI: / Fig. 1. Flowchart of included.

Individualized prediction of hepatocellular carcinoma occurrence in a large cohort of patients with cirrhosis Astrid Marot, Jean Henrion, Jean-François.

Volume 153, Issue 4, Pages (October 2017)

Hepatitis B and C virus-related carcinogenesis

Psychiatric disorders among veterans with hepatitis C infection

Changing pattern of chronic hepatitis D in Southern Europe

Volume 124, Issue 4, Pages (April 2003)

Volume 69, Issue 2, Pages (August 2018)

Temporal Trends of Nonalcoholic Fatty Liver Disease–Related Hepatocellular Carcinoma in the Veteran Affairs Population Sahil Mittal, Yvonne H. Sada,

Hepatocellular Carcinoma in Patients With Cryptogenic Cirrhosis

Effects of IL28B rs CC Genotype on Metabolic Profile and Sustained Virologic Response in Patients With Genotype 1 Chronic Hepatitis C Salvatore.

Appendectomy is followed by increased risk of Crohn's disease

Covering the Cover Gastroenterology

Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C Chi–Jen Chu, Munira Hussain,

Volume 120, Issue 3, Pages (February 2001)

Cheng-Yuan Peng, Rong-Nan Chien, Yun-Fan Liaw Journal of Hepatology

European Association for the Study of the Liver Journal of Hepatology

Long-Term Outcomes of Nonalcoholic Fatty Liver Disease: From Nonalcoholic Steatohepatitis to Nonalcoholic Steatofibrosis Zobair M. Younossi Clinical.

Hepatocellular Carcinoma in the Absence of Cirrhosis in United States Veterans Is Associated With Nonalcoholic Fatty Liver Disease Sahil Mittal, Hashem.

Volume 121, Issue 4, Pages (October 2001)

Volume 152, Issue 5, Pages e1 (April 2017)

Volume 120, Issue 4, Pages (March 2001)

Michael Charlton Clinical Gastroenterology and Hepatology

Volume 122, Issue 2, Pages (February 2002)

Lei Yu, Dana A. Sloane, Chuanfa Guo, Charles D. Howell

Hepatitis B and C virus-related carcinogenesis

George N. Ioannou, Meaghan F. Splan, Noel S. Weiss, George B

Volume 120, Issue 1, Pages (January 2001)

Lise L. Kjaergard, Sarah L. Frederiksen, Christian Gluud

AGA technical review on nonalcoholic fatty liver disease

Nonalcoholic Steatohepatitis Is the Fastest Growing Cause of Hepatocellular Carcinoma in Liver Transplant Candidates Zobair Younossi, Maria Stepanova,

Sharon J. Hutchinson, Sheila M. Bird, David J. Goldberg

Psychiatric disorders among veterans with hepatitis C infection

Image of the month Gastroenterology

Independent of Cirrhosis, Hepatocellular Carcinoma Risk Is Increased with Diabetes and Metabolic Syndrome Allison J. Kasmari, MD, Amy Welch, MD, MSN,

Factors Associated With Increased Risk of De Novo or Recurrent Hepatocellular Carcinoma in Patients With Cirrhosis Treated With Direct-Acting Antivirals.

Prevalence and Prognostic Significance of the Presence of Esophageal Varices in Patients With Hepatocellular Carcinoma Edoardo Giovanni Giannini, Domenico.

Volume 141, Issue 4, Pages (October 2011)

Histological outcome during long-term lamivudine therapy

Ju Dong Yang, W. Ray Kim, Ritika Coelho, Teresa A. Mettler, Joanne T

AGA technical review on osteoporosis in gastrointestinal diseases

Volume 122, Issue 4, Pages (April 2002)

Liver Transplantation for Hepatocellular Carcinoma

Volume 126, Issue 4, Pages (April 2004)

Prognosis following spontaneous HBsAg seroclearance in chronic hepatitis B patients with or without concurrent infection Yi–Cheng Chen, I.–Shyan Sheen,

Volume 149, Issue 1, Pages (July 2015)

Hepatic deficiency of interleukin 10 in chronic hepatitis C

Hashem B. El-serag, Thomas Tran, James E. Everhart Gastroenterology

Volume 152, Issue 5, Pages e1 (April 2017)

Racial Differences in Survival of Hepatocellular Carcinoma in the United States: A Population-Based Study Jessica A. Davila, Hashem B. El–Serag Clinical.

Effect of Potassium Canrenoate, an Anti-aldosterone Agent, on Incidence of Ascites and Variceal Progression in Cirrhosis Luigi Bolondi, Fabio Piscaglia,

Hisashi Moriguchi, Makoto Kobayashi, Raymond T. Chung, Chifumi Sato

Volume 124, Issue 3, Pages (March 2003)

Hepatitis B genotypes correlate with tumor recurrence after curative resection of hepatocellular carcinoma Jin-de Chen, Chun-jen Liu, Po-huang Lee, Pei-jer.

Volume 156, Issue 4, Pages (March 2019)

Incidence of Hepatocellular Carcinoma Among US Patients With Cirrhosis of Viral or Nonviral Etiologies Robert D. Mair, Antonia Valenzuela, Nghiem B.

Presentation transcript:

Volume 123, Issue 1, Pages 134-140 (July 2002) Expanding the natural history of nonalcoholic steatohepatitis: From cryptogenic cirrhosis to hepatocellular carcinoma Elisabetta Bugianesi, Nicola Leone, Ester Vanni, Giulio Marchesini, Franco Brunello, Patrizia Carucci, Alessandro Musso, Paolo De Paolis, Lorenzo Capussotti, Mauro Salizzoni, Mario Rizzetto Gastroenterology Volume 123, Issue 1, Pages 134-140 (July 2002) DOI: 10.1053/gast.2002.34168 Copyright © 2002 American Gastroenterological Association Terms and Conditions

Fig. 1 Prevalence of (A) obesity, (B) hypertriglyceridemia, and (C) type 2 diabetes mellitus in patients with HCC, grouped according to etiology. Closed bars represent patients with CC; gray bars, those with HCV; hatched bars, those with HBV; and open bars, those with alcoholic cirrhosis. The significance of differences between the CC group and the whole control group are calculated. Gastroenterology 2002 123, 134-140DOI: (10.1053/gast.2002.34168) Copyright © 2002 American Gastroenterological Association Terms and Conditions